Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 20.6k | $0.00 | $0 | | 03/02/2023 |
03/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 36.2k | $65.32 | $2.4M | | 03/02/2023 |
03/04/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 77.9k | $29.91 | $2.3M | | 03/04/2022 |
03/04/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 41.2k | $0.00 | $0 | | 03/04/2022 |
11/18/2021 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 142 | $35.20 | $5k | By UTMA account | 11/18/2021 |
11/18/2021 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 145 | $34.30 | $5k | By UTMA account | 11/18/2021 |
11/18/2021 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 141 | $35.43 | $5k | By UTMA account | 11/18/2021 |
11/18/2021 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 527 | $35.50 | $18.7k | | 11/18/2021 |
11/12/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 36.1k | $39.26 | $1.4M | | 11/12/2021 |
03/05/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 36.1k | $65.02 | $2.3M | | 03/05/2021 |
03/05/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 19.2k | $0.00 | $0 | | 03/05/2021 |
06/29/2020 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 777 | $76.64 | $59.5k | | 06/29/2020 |
03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 48.2k | $45.14 | $2.2M | | 03/17/2020 |
03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 14.8k | $0.00 | $0 | | 03/17/2020 |
03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (Right to Buy) | 60.9k | $45.14 | $2.7M | | 03/17/2020 |
03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Restricted Stock Units | 18.6k | $0.00 | $0 | | 03/17/2020 |
10/10/2019 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (right to buy) | 25.8k | $17.61 | $454.6k | | 10/10/2019 |
09/26/2019 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 2.2k | $24.80 | $54.1k | | 09/26/2019 |
06/11/2019 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 1.9k | $20.80 | $39.9k | | 06/11/2019 |
03/19/2019 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 60 | $12.69 | $761.4 | By UTMA account | 03/19/2019 |
03/19/2019 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 5.3k | $12.58 | $67.2k | | 03/19/2019 |
03/19/2019 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (right to buy) | 75.1k | $12.95 | $972.6k | | 03/19/2019 |
06/19/2018 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 30.6k | $3.10 | $94.9k | | 06/19/2018 |
06/19/2018 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 400 | $3.05 | $1.2k | | 06/19/2018 |
05/16/2018 | Axsome Therapeutics, Inc. | AXSM | Grant | Employee Stock Option (right to buy) | 132k | $3.50 | $462k | | 05/16/2018 |